Taking over after Horning leaves on December 31 is Levi Garraway, who has just left his role as Eli Lilly’s head of oncology R&D after three years. Horning has been at Roche’s Genentech ...

罗氏首席医疗官Levi Garraway表示：“我们很高兴看到，接受口服GLP-1疗法CT-996治疗的患者出现了临床意义上的体重减轻，这最终可能帮助患者同时解决 ...

Genentech’s chief medical officer Levi Garraway highlighted the potential of Evrysdi in combination with newborn screening programmes: “These two-year findings confirm the potential of early ...